Cargando…
Targeting mesenchymal stem cell therapy for severe pneumonia patients
Pneumonia is the inflammation of the lungs and it is the world’s leading cause of death for children under 5 years of age. The latest coronavirus disease 2019 (COVID-19) virus is a prominent culprit to severe pneumonia. With the pandemic running rampant for the past year, more than 1590000 deaths ha...
Autores principales: | Lam, Guy, Zhou, Yuan, Wang, Jia-Xian, Tsui, Yat-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933990/ https://www.ncbi.nlm.nih.gov/pubmed/33708343 http://dx.doi.org/10.4252/wjsc.v13.i2.139 |
Ejemplares similares
-
Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells
por: Dupuis, Victoria, et al.
Publicado: (2021) -
Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials
por: Labrador-Velandia, Sonia, et al.
Publicado: (2016) -
Mesenchymal stem cells for cartilage regeneration in osteoarthritis
por: Kristjánsson, Baldur, et al.
Publicado: (2017) -
Effect of aging on behaviour of mesenchymal stem cells
por: Fafián-Labora, Juan Antonio, et al.
Publicado: (2019) -
Isolation and characterization of mesenchymal stem cells in orthopaedics and the emergence of compact bone mesenchymal stem cells as a promising surgical adjunct
por: Anastasio, Albert, et al.
Publicado: (2020)